NAD+ Precursors Like Nicotinamide Riboside and Nicotinamide Mononucleotide Can Help Fight Against COVID-19
Nikhil Prasad Fact checked by:Thailand Medical News Team Dec 24, 2024 14 hours, 26 minutes ago
Medical News: Understanding NAD's Role in Immunity and Energy
A groundbreaking study explores how NAD+ metabolism could offer new hope in the battle against COVID-19. Nicotinamide adenine dinucleotide (NAD+) is a crucial molecule for cellular energy production and immune system regulation.
NAD+ Precursors Like Nicotinamide Riboside and Nicotinamide Mononucleotide
Can Help Fight Against COVID-19
The study, spearheaded by researchers from Xiang’an Hospital of Xiamen University and Peking University People’s Hospital in China, delves into the intricate ways NAD+ influences immune responses and how its modulation might provide therapeutic benefits.
COVID-19 has been a persistent global challenge for over three years. Despite advancements in vaccines and antiviral treatments, managing severe cases remains a significant hurdle. Immunotherapies, such as IL-6 monoclonal antibodies and JAK inhibitors, show limited efficacy, necessitating alternative approaches. This
Medical News report examines the potential of targeting NAD+ metabolism as a novel strategy to address these gaps.
The Science Behind NAD+ and COVID-19
NAD+ is an essential molecule found in every cell, participating in processes like energy metabolism, DNA repair, and immune regulation. In COVID-19, NAD+ metabolism undergoes significant disruption. Researchers found that NAD+ levels plummet in severe cases, coinciding with the overactivation of NAD+-consuming enzymes such as poly (ADP-ribose) polymerases (PARPs) and CD38. These enzymes, while critical in normal immune responses, exacerbate inflammation and energy depletion when dysregulated.
“Our findings highlight the critical role of NAD+ in maintaining immune cell function and mitigating inflammatory responses,” said lead researcher Dr. Zhancheng Gao. The study suggests that restoring NAD+ levels could improve the immune system’s ability to combat SARS-CoV-2, the virus causing COVID-19.
Exploring Therapeutic Interventions
-NAD+ Precursors as Supplements
One approach involves supplementing NAD+ precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). These compounds help replenish NAD+ levels, enhancing energy production and immune function. Animal studies demonstrated that NAD+ supplementation reduced inflammation and improved outcomes in SARS-CoV-2-infected mice. Preliminary human trials also show promising results, with faster recovery times and improved biochemical markers among patients receiving NAD+ precursors.
-Targeting NAD+-Consuming Enzymes
Another strategy focuses on inhibiting overactive NAD+-consuming enzymes. For example, PARP inhibitors like rucaparib have shown potential in reducing SARS-CoV-2 replication and inflammation. Similarly, targeting CD38, an enzyme upregulated in severe COVID-19 cases, could mitigate NAD+ depletion and its downstream effects. However, research
ers caution that suppressing these enzymes may pose risks, such as reduced DNA repair capabilities or increased susceptibility to infections.
Implications for Long COVID
Chronic fatigue and persistent inflammation are hallmarks of long COVID, affecting millions worldwide. The study links these symptoms to prolonged NAD+ depletion. By addressing this metabolic imbalance, NAD+-boosting therapies could alleviate long COVID’s debilitating effects. Researchers noted that NAD+ plays a vital role in cellular repair mechanisms, and its restoration may reverse the mitochondrial dysfunction and oxidative stress underlying these symptoms.
Key Study Findings
-NAD+ Depletion in COVID-19: Severe cases exhibit significant reductions in NAD+ levels due to heightened activity of enzymes like PARPs and CD38.
-Immune Dysregulation: NAD+ depletion impairs immune cell function, contributing to cytokine storms and chronic inflammation.
-Therapeutic Potential: Supplementing NAD+ precursors or inhibiting NAD+-consuming enzymes shows promise in preclinical and early human studies.
-Broad Applications: Beyond COVID-19, these findings could inform treatments for other infectious diseases and conditions involving immune dysfunction.
Future Directions
The researchers emphasize the need for large-scale clinical trials to confirm these findings and optimize NAD+-based therapies. They also advocate for exploring combination treatments that integrate NAD+ modulation with traditional antiviral and anti-inflammatory strategies. Understanding individual variations in NAD+ metabolism could pave the way for personalized medicine approaches, enhancing treatment efficacy and minimizing side effects.
Conclusion
The study sheds light on the critical role of NAD+ metabolism in COVID-19 pathology and treatment. By targeting this metabolic pathway, researchers aim to bolster the immune system’s defenses, reduce inflammation, and improve patient outcomes. As the global fight against COVID-19 continues, this innovative approach could offer a new weapon in our therapeutic arsenal.
The study findings were published in the peer-reviewed journal: Vaccines.
https://www.mdpi.com/2076-393X/13/1/1
For the latest COVID-19 News, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/nad-metabolism-and-its-emerging-role-in-covid-19-treatment
https://www.thailandmedical.news/news/covid-19-supplements-studies-show-that-nad-nicotinamide-adenine-dinucleotide-could-play-a-key-role-in-treating-covid-19-and-long-covid
https://www.thailandmedical.news/news/mitochondrial-function-and-energy-production-in-mtdps-liver-like-cells-can-be-restored-by-nicotinamide-adenine-dinucleotide--nad
https://www.thailandmedical.news/news/covid-19-treatments-metabolic-activators-such-as-n-acetyl-l-cysteine,-l-carnitine-tartrate,-nicotinamide-riboside,-l-serine-can-reduce-recovery-time-i
https://www.thailandmedical.news/news/breaking-study-shockingly-finds-that-a-form-of-vitamin-b3-supplements-actually-increases-cancer-prevalence-and-aids-in-breast-cancer-metastases
https://www.thailandmedical.news/news/hiv-news-hong-kong-researchers-make-breakthrough-in-cd4-t-cell-recovery-treatment-by-using-nicotinamide-mononucleotide-nmn
https://www.thailandmedical.news/news/the-promise-and-challenges-of-nicotinamide-mononucleotide-nmn-supplements
Share
Tweet
Share
